Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial is testing a new powder medication for people with moderate to severe acne rosacea. They want to see if it is safe and effective.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy as measured by Investigator Global Assessment (IGA)
Efficacy as measured by lesion counts
Secondary outcome measures
Incidence of adverse events as a measure of safety and tolerability
Trial Design
2Treatment groups
Experimental Treatment
Group I: Study Treatment 2Experimental Treatment1 Intervention
Placebo powder mixed with Hydrogen Peroxide
Group II: Study Treatment 1Experimental Treatment1 Intervention
DMT310 Powder mixed with Hydrogen Peroxide
Find a Location
Who is running the clinical trial?
Dermata TherapeuticsLead Sponsor
5 Previous Clinical Trials
983 Total Patients Enrolled
1 Trials studying Rosacea
107 Patients Enrolled for Rosacea
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger